Page last updated: 2024-10-31

nocodazole and Scleroderma, Systemic

nocodazole has been researched along with Scleroderma, Systemic in 2 studies

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spinette, S1
Lengauer, C1
Mahoney, JA1
Jallepalli, PV1
Wang, Z1
Casciola-Rosen, L1
Rosen, A1
Simerly, C1
Balczon, R1
Brinkley, BR1
Schatten, G1

Other Studies

2 other studies available for nocodazole and Scleroderma, Systemic

ArticleYear
Ufd2, a novel autoantigen in scleroderma, regulates sister chromatid separation.
    Cell cycle (Georgetown, Tex.), 2004, Volume: 3, Issue:12

    Topics: Apoptosis; Autoantibodies; Autoantigens; Case-Control Studies; Cell Cycle Proteins; Chromatids; Chro

2004
Microinjected centromere [corrected] kinetochore antibodies interfere with chromosome movement in meiotic and mitotic mouse oocytes.
    The Journal of cell biology, 1990, Volume: 111, Issue:4

    Topics: Anaphase; Animals; Antibodies; Autoantibodies; Centromere; Chromosomes; Cross Reactions; Humans; Imm

1990